Experts Recommend Personalized Approach to Breast Cancer Screening
By MedImaging International staff writers Posted on 03 Jan 2017 |
Image: Digital mammograms (top) compared with Contrast-Enhanced Digital Mammography (CEDM) images (bottom) for breast cancer screening (Photo courtesy of Dr. John Lewin).
Experts in the US have recommended a risk-based personalized approach to breast cancer screening to ensure improved, safer and less expensive cancer care.
Current 5-year breast cancer survival rates have reached 90% as a result of both improved treatment and screening, but this could still be improved further by taking into account the differences between women with dense breasts, those with a personal history of breast cancer, and carriers of the BRCA1 and BRCA2 gene mutations for example.
The recommendations presented by the experts from the George Washington University (Washington DC, USA) and the Memorial Sloan Kettering Cancer Center (New York, NY, USA) include annual screening using both mammography and ultrasound modalities for women aged 40 and older who have a lifetime risk of breast cancer. In addition, since mammography screening alone is unable to find a third of all cancers in women with dense breast tissue, they could benefit from the addition of ultrasound screening, as revealed in a recent study of 15,000 women.
Mammography screening is not suitable for women under 40 years of age who carry the BRCA1 mutation. As an alternative, annual or biannual Magnetic Resonance Imaging (MRI) scans could increase cancer detection and reduce radiation exposure for BRCA1 carriers aged 25 to 40. For BRA1 carriers older than 40, alternating MRI and mammography screening every six months could be suitable. Contrast-Enhanced Digital Mammography (CEDM) is another possible alternative for routine mammography screening.
Related Links:
George Washington University
Memorial Sloan Kettering Cancer Center
Current 5-year breast cancer survival rates have reached 90% as a result of both improved treatment and screening, but this could still be improved further by taking into account the differences between women with dense breasts, those with a personal history of breast cancer, and carriers of the BRCA1 and BRCA2 gene mutations for example.
The recommendations presented by the experts from the George Washington University (Washington DC, USA) and the Memorial Sloan Kettering Cancer Center (New York, NY, USA) include annual screening using both mammography and ultrasound modalities for women aged 40 and older who have a lifetime risk of breast cancer. In addition, since mammography screening alone is unable to find a third of all cancers in women with dense breast tissue, they could benefit from the addition of ultrasound screening, as revealed in a recent study of 15,000 women.
Mammography screening is not suitable for women under 40 years of age who carry the BRCA1 mutation. As an alternative, annual or biannual Magnetic Resonance Imaging (MRI) scans could increase cancer detection and reduce radiation exposure for BRCA1 carriers aged 25 to 40. For BRA1 carriers older than 40, alternating MRI and mammography screening every six months could be suitable. Contrast-Enhanced Digital Mammography (CEDM) is another possible alternative for routine mammography screening.
Related Links:
George Washington University
Memorial Sloan Kettering Cancer Center
Latest MRI News
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs